Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 662 results for "Cgix"

Cancer Genetics (CGIX) Looks Good: Stock Rises 8%

Cancer Genetics, Inc. (CGIX) was a big mover last session with its shares rising just over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the ... Yahoo! Finance, 1 week ago

Cancer Genetics wins second patent for FHACT test to improve cervical cancer detection for up to 2m women in the US each year

Cancer diagnostics company Cancer Genetics (NasdaqCM:CGIX) disclosed on Tuesday the receipt of the second US patent (US Patent No. 8,883,414) for its proprietary FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer detection in ...
 Individual.com1 month ago

Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors

RUTHERFORD, N.J. and HYDERABAD, India, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc . ( Nasdaq:CGIX ) ("CGI" or "the Company"), an emerging leader in DNA-based cancer diagnostics, announced today the addition of Venkatadri Bobba to Cancer ...
 CEOWorld Magazine6 days ago Cancer Genetics, Inc. Strengthens Clinical Trials Leadership Team With Hire of Rob Fannon as Vice President of Operations  MoneyShow.com1 week ago Cancer Genetics, Inc. (CGIX) Announces Launch Of Targeted Next Generation Sequencing Based Panel For Chronic Lymphocytic Leukemia, Focus::CLL 12/8/2014  ClinicSpace2 weeks ago Cancer Genetics, Inc. to Receive $530,000 Through New Jersey Technology Business Tax Program  CEOWorld Magazine1 week ago

RedChip Issues Research Note on Cancer Genetics

RedChip Companies, Inc., today announced it has issued a research note on Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers. To receive ...
 Individual.com1 month ago Dave Gentry Features Top 5 Healthcare Stocks for 2015 on This Week's RedChip Money Report on Fox Business and Bloomberg  CEOWorld Magazine5 days ago RedChip Receives Top Praise for Its Performance  SearchBug2 weeks ago

Leading Small-Cap Stars Health Care Stock for December 9 Morning Session is Cancer Genetics Inc. (CGIX)

The world of small-cap health care investing is one of huge booms and major busts. However,'s Small-Cap Stars , our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps ...
 Equities.com1 week ago

Cancer Genetics Director Acquires $34,652 in Stock (CGIX)

Cancer Genetics (NASDAQ:CGIX) Director John Pappajohn bought 5,589 shares of Cancer Genetics stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average cost of $6.20 per share, for a total transaction of ...
 SleekMoney3 days ago Insider Buying: John Pappajohn Purchases 5,589 Shares of Cancer Genetics Stock (CGIX)  Ticker Report4 days ago Insider Buying: John Pappajohn Buys 5,773 Shares of Cancer Genetics Stock (CGIX)  Ticker Report1 week ago Insider Buying: Cancer Genetics Director Acquires 5,773 Shares of Stock (CGIX)  SleekMoney1 week ago

Leading Health Care Stock for Small-Cap Stars is Cancer Genetics Inc. (CGIX) for December 10

Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However,'s Small-Cap Stars , our proprietary list of small-cap companies with ...
 Equities.com1 week ago

Cancer Genetics (CGIX) Names New VP of RTP Operations

Visit at for the
 Wall Street Business Network1 week ago Cancer Genetics (CGIX) Licensed by CLIA to Perform Focus::CLL  Wall Street Business Network2 weeks ago Cancer Genetics (CGIX) Attains Another U.S. Patent Covering FHACT for Cervical Cancer  Town Hall1 month ago

Cancer Genetics Sets New 12-Month Low at $5.76 (CGIX)

Cancer Genetics (NASDAQ:CGIX)'s share price reached a new 52-week low during trading on Wednesday , Analyst RN reports. The company traded as low as $5.76 and last traded at $5.84, with a volume of 38,467 shares traded. The stock had previously ...
 American Banking News1 month ago

Cancer Genetics (CGIX) Releases Quarterly Earnings Results

Cancer Genetics (NASDAQ:CGIX) posted its quarterly earnings results on Monday. The company reported ($0.41) earnings per share for the quarter, beating the analysts consensus estimate of ($0.51) by $0.10, AR Network reports. On the ratings front, ...
 SleekMoney1 month ago Cancer Genetics (CGIX) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS  American Banking News1 month ago Morning Market Movers  Benzinga.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less